Relation Therapeutics is a London-based TechBio company focused on drug discovery. It combines active-graph machine learning, single-cell analysis, and deep clinical insights to develop medicines, operating at the intersection of computational biology and biotechnology.
The company's central platform, Lab-in-the-Loop, integrates single-cell multi-omics from patient tissue, functional assays, and computational approaches. This system is designed to map disease biology from cause to cure, driving the discovery pipeline.
Relation Therapeutics has secured over $60 million in seed funding to support its research and platform development.
